跳至主要内容
临床试验/CTRI/2024/10/075727
CTRI/2024/10/075727尚未招募4 期

Comparison between Oral Dydrogesterone and Oral Micronized Progesterone in Threatened Abortion : A randomized controlled trial

Rohilkhand Medical College and Hospital, Bareilly1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2024年11月5日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
76
试验地点
1
主要终点
- To compare Dydrogesterone and Oral Micronized Progesterone in Threatened Abortion

研究概览

简要总结

Abortion can be defined as the extraction or expulsion of a foetus or an embryo weighing less than 500 grams at less than 20 weeks period of gestation (WHO and The National Centre of Health Statistics), incapable of independent survival. Abortion is a common outcome occurring in 10-15% of total clinically recognised pregnancies. It can be a devastating event for women leading to stress, depression, anxiety, delay in family completion, economic burden and hence family tension.

Of the many clinical presentations of abortion, at one end we have inevitable abortion which presents with bleeding, cervical dilatation and pain in the abdomen, indicating impending abortion and on the other we have threatened abortion where excluding genetic causes timely intervention can lead to a positive fetomaternal outcome. Threatened abortion presents with spotting per vaginum, with or without abdominal discomfort less than 20 weeks of gestation, with an alive intrauterine fetus. An important prerequisite of threatened abortion is closed internal os in per vaginum examination. Pathogenicity of threatened abortion is multifactorial such as chromosomal anomalies, structural anomalies incompatible with life, infections, uterine anomalies, uncontrolled diabetes, immunological dysfunction like APLA, endocrine factors like levels of thyroid hormone, and absence of adequate progesterone concentration. Decreased progesterone due to dysfunctional corpus luteum is one of the main reasons for threatened abortion. Hence, exogenous progesterone is prescribed as the primary treatment for threatened abortion besides bed rest.

Progesterone is a female sex hormone and as the name suggests is " Pro - Gestation" by aiding implantation, maintaining pregnancy and preventing early contractions of the uterus. Progesterone supplements are available in the form of injections, tablets, capsules and vaginal suppositories. Maximum compliance is noted in the oral route of administration. On the contrary, oral administration of natural progesterone is found less effective as it is highly lipophilic and insoluble in water. In 1980 oral micronized progesterone in the form of suspension of oil came as a boon. It solved the problem of absorption and it lacks the adverse metabolic effects of synthetic progesterone as well. Dydrogesterone is an exogenous synthetic progesterone that is identical to natural synthetic progesterone in structure and pharmacological actions. It doesn’t exhibit androgenic (in the mother) and estrogenic (in the fetus) side effects like other synthetic progestogens in use.

To prevent threatened abortions and to safeguard pregnancy, progesterone has been the choice of drug and is widely prescribed all over. Even so, there is a paucity of studies to manage the condition. As threatened abortion remains one of the important pregnancy outcomes, it’s management requires more evidence-based research. This study compares oral dydrogesterone and oral micronized progesterone in threatened abortion, its efficacy and side effects.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • All Patients presenting with the threatened abortion of age more than or equal to 18 years with a live intrauterine gestation of less than or equal to 20 weeks confirmed by Ultrasonography.

排除标准

  • Known parental chromosomal anomaly.
  • Heavy bleeding per vaginum requiring surgical intervention.
  • Known allergy to any of the two or both the drugs.
  • Case of recurrent miscarriage i.e. three or more spontaneous miscarriages in the past.
  • Suspected or confirmed breast or genital cancer, hepatic disease or tumour.

结局指标

主要结局

- To compare Dydrogesterone and Oral Micronized Progesterone in Threatened Abortion

时间窗: Follow up visits scheduled at 7th, 14th and 21st day of prescription

- To determine the efficacy and safety of Oral dydrogesterone in threatened abortion.

时间窗: Follow up visits scheduled at 7th, 14th and 21st day of prescription

- To assess the efficacy and safety of Oral micronized progesterone in threatened abortion.

时间窗: Follow up visits scheduled at 7th, 14th and 21st day of prescription

次要结局

  • - duration and extent of bleeding(- fetomaternal outcomes.)

研究者

申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Jairath Nikki Brijbhushan

Rohilkhand Medical College and Hospital

研究点 (1)

Loading locations...

相似试验